Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
CancerTech company providing oncology teams AI insights to enhance diagnostic accuracy and improve patient outcomes
Innovative Solution
ToMore Vision is a cancertech company focused on advancing cancer prognosis through AI-driven solutions. Our platform empowers multidisciplinary teams (MDTs) with precise insights to improve diagnostic accuracy and support better patient outcomes in oncology.
People
Founders
Hamed Mehrabi
About
ToMore Vision is a cancertech company focused on advancing cancer prognosis through AI-driven solutions. Our platform empowers multidisciplinary teams (MDTs) with precise insights to improve diagnostic accuracy and support better patient outcomes in oncology.
Something missing or incorrect on this page? Help us enrich this information
